In this article by IFPMA and Innovative Medicines Canada, they called on leaders to make health innovation a cornerstone of G7 policy. The open letter asked leaders to invest in medical R&D, strengthen global health security, and address trade barriers. It highlights how innovation drives better patient outcomes, economic resilience, and preparedness for future health crises. IFPMA and IMC outline that prioritizing research and collaboration now will ensure faster access to breakthroughs for patients worldwide.